University of Illinois

Morton Grove Pharmaceuticals, Inc.

Michael J Groves

Melvin E Klegerman

M Hayat Alkan

Kamel F Egbaria

Ronghua Wang

A pharmaceutical composition contains cyclosporine as the active ingredient. More specifically, the composition is an orally administered pharmaceutical formulation in the form of a spontaneous emulsion comprising cyclosporine, ethanol ethyl oleate and polyoxyethylene glycerol trioleate. A method for preparing an orally administered pharmaceutical composition involves first dissolving cyclosporine in ethanol. Polyoxyethylene glycerol trioleate and an oil component are then added, mixed and diluted in an aqueous media to form a spontaneous emulsion.

Spontaneous emulsions containing cyclosporine

A method for preparing a highly potent glycan extract from Mycobacteria by admixing at least one Mycobacterium with an aqueous solution of concentrated urea.

Method for isolating high molecular weight antineoplastic glycans using

A purified hot-water extract from Mycobacterium bovis (BCG vaccine) has been found to have significant antitumor activity against a mouse bladder tumor model and a murine sarcoma in vivo, but not in vitro. The material, termed PS1A1, has an approximate molecular weight of between 60 and 90 kDa, is freely soluble in water, but has low solubility in acetone or ethanol, and is remarkably heat-stable.

Mixture having antitumor activities

A packing material for the treatment of infections, particularly of the teeth and gums. A biocompatible, polymeric carrier material, typically calcium alginate, has dispersed therein an antibiotic ester which typically defines at least one ester group of 10 to 18 carbon atoms per molecule. The antibiotic ester is present in the polymeric carrier in an initial concentration sufficient to allow the continuous, controlled release of at least an inhibitory concentration of free antibiotic as a hydrolysis product from the antibiotic ester. The rate of release of free antibiotic is influenced by the presence of bacterial lipase, so that a higher concentration of infectious bacteria causes the release of higher concentrations of free antibiotic, hydrolyzed from the ester, in a feedback loop.

Device and method for treatment of infections

A packing material for the treatment of infections, particularly of the teeth and gums. A biocompatible, polymeric carrier material, typically calcium alignate, has dispersed therein an antibiotic ester which typically defines at least one ester group of 10 to 18 carbon atoms per molecule. The antibiotic ester is present in the polymeric carrier in an initial concentration sufficient to allow the continuous, controlled release of at least an inhibitory concentration of free antibiotic as a hydrolysis product from the antibiotic ester. The rate of release of free antibiotic is influenced by the presence of bacterial lipase, so that a higher concentration of infectious bacteria causes the release of higher concentrations of free antibiotic, hydrolyzed from the ester, in a feedback loop.

Packing material for treatment of infections

Apparatus and methods are provided for coating relatively small quantities of particles including tablets, pellets, or granules. The device effectively fluidizes the particles to be coated by controlled vibration of a perforated platform through which drying air is passed during intermittent spraying of the particles with a solution of organic or aqueous-based coating material. The method coats individual tablets having as low a mass as 50 mg and coats quantities ranging from less than about 50 mg to 10 g of tablets, pellets, or granules.

Particle coating apparatus for small-scale processing

Mycobacterium bovis BCG suspensions are treated with a protease enzyme such as pronase, resulting in the production of suspensions having smaller aggregates and single cells. Such suspensions, when processed into vaccines, exhibit improved immunizing potential against cancer and would be expected to exhibit improved immunizing potential against tuberculosis.

Process for the enzymatic dispersal of Mycobacterium bovis - BCG

The present invention provides methods and materials for coating relatively small quantities of particles including tablets, pellets or granules. The device effectively fluidizes the particles to be coated by controlled vibration of a perforated platform through which drying air is passed during intermittent spraying of the particles with a solution of organic or aqueous-based coating material. The method coats individual tablets having as low a mass as 50 mg and coats quantities ranging from less than about 50 mg to 10 g of tablets, pellets, or granules.

Growing community of inventors

Lake Forest, IL, United States of America

Michael J Groves